Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma (NCT06039111)
Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma: The IGNITE-V Study
🩺 Plain-English Summary (8th-Grade Level)
The aim of this study is to confirm prospectively if the use of near infrared-indocyanine green (NIR-ICG) alone offers similar accuracy and sensitivity to the gold standard dual technique for sentinel lymph node detection in early stage vulvar cancer.
Who can join: Review the eligibility criteria below.
Location: Hamilton Health Sciences — Hamilton, Ontario
Age range: 18 Years
🧪 Interventions in This Study
- ICG alone (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hamilton Health Sciences — Hamilton, Ontario
📞 Contact the Study Coordinator
Phone: (905) 387-9495
Email: nica@hhsc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Vulvar Cancer
- Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer — Basking Ridge, New Jersey
- Cisplatin+Pembrolizumab+RT in Vulvar Cancer — Boston, Massachusetts
- Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. — Toronto, Ontario
- STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision — Vancouver, British Columbia
- Groningen International Study on Sentinel Nodes in Vulvar Cancer-III — Orange, California
Explore by condition: All Vulvar Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.